{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:04:23Z","timestamp":1790359463758,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"DOI":"10.1007\/s00393-026-01864-8","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:57:54Z","timestamp":1790359074000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Psoriasis-Arthritis als MHC-I-assoziierte Erkrankung","Psoriatic arthritis as MHC-I-associated disease"],"prefix":"10.1007","author":[{"given":"Michaela","family":"K\u00f6hm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Rzehak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Ninosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Figat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Behrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"1864_CR1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-1-4419-0298-6_4","volume":"649","author":"M Benjamin","year":"2009","unstructured":"Benjamin\u00a0M, Mcgonagle\u00a0D (2009) The enthesis organ concept and its relevance to the spondyloarthropathies. Adv Exp Med Biol 649:57\u201370","journal-title":"Adv Exp Med Biol"},{"key":"1864_CR2","first-page":"177","volume":"10","author":"J Bowes","year":"2010","unstructured":"Bowes\u00a0J, Barton\u00a0A (2010) The genetics of psoriatic arthritis: lessons from genome-wide association studies. Discov Med 10:177\u2013183","journal-title":"Discov Med"},{"key":"1864_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev-immunol-032414-112110","volume":"33","author":"P Bowness","year":"2015","unstructured":"Bowness\u00a0P (2015) HLA-B27. Annu Rev Immunol 33:29\u201348","journal-title":"Annu Rev Immunol"},{"key":"1864_CR4","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/art.39494","volume":"68","author":"L Eder","year":"2016","unstructured":"Eder\u00a0L, Haddad\u00a0A, Rosen\u00a0CF et\u00a0al (2016) The Incidence and Risk Factors for Psoriatic Arthritis in Patients With Psoriasis: A Prospective Cohort Study. Arthritis Rheumatol 68:915\u2013923","journal-title":"Arthritis Rheumatol"},{"key":"1864_CR5","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nri3707","volume":"14","author":"SL Gaffen","year":"2014","unstructured":"Gaffen\u00a0SL, Jain\u00a0R, Garg\u00a0AV et\u00a0al (2014) The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat Rev Immunol 14:585\u2013600","journal-title":"Nat Rev Immunol"},{"issue":"Suppl 2","key":"1864_CR6","doi-asserted-by":"publisher","first-page":"ii14","DOI":"10.1136\/ard.2004.032482","volume":"64","author":"DD Gladman","year":"2005","unstructured":"Gladman\u00a0DD, Antoni\u00a0C, Mease\u00a0P et\u00a0al (2005) Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 64(Suppl 2):ii14\u2013ii17","journal-title":"Ann Rheum Dis"},{"key":"1864_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41584-020-0454-9","volume":"16","author":"E Gracey","year":"2020","unstructured":"Gracey\u00a0E, Vereecke\u00a0L, Mcgovern\u00a0D et\u00a0al (2020) Revisiting the gut-joint axis: links between gut inflammation and spondyloarthritis. Nat Rev Rheumatol 16:415\u2013433","journal-title":"Nat Rev Rheumatol"},{"key":"1864_CR8","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1136\/annrheumdis-2013-204858","volume":"74","author":"M Haroon","year":"2015","unstructured":"Haroon\u00a0M, Gallagher\u00a0P, Fitzgerald\u00a0O (2015) Diagnostic delay of more than 6\u00a0months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis 74:1045\u20131050","journal-title":"Ann Rheum Dis"},{"key":"1864_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.semarthrit.2017.12.008","volume":"48","author":"GS Kaeley","year":"2018","unstructured":"Kaeley\u00a0GS, Eder\u00a0L, Aydin\u00a0SZ et\u00a0al (2018) Enthesitis: A hallmark of psoriatic arthritis. Semin Arthritis Rheum 48:35\u201343","journal-title":"Semin Arthritis Rheum"},{"key":"1864_CR10","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nrrheum.2015.147","volume":"11","author":"D Mcgonagle","year":"2015","unstructured":"Mcgonagle\u00a0D, Aydin\u00a0SZ, G\u00fcl\u00a0A et\u00a0al (2015) \u2019MHC-I-opathy\u2019-unified concept for spondyloarthritis and Beh\u00e7et disease. Nat Rev Rheumatol 11:731\u2013740","journal-title":"Nat Rev Rheumatol"},{"key":"1864_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1136\/annrheumdis-2016-209709","volume":"76","author":"PJ Mease","year":"2017","unstructured":"Mease\u00a0PJ, Van Der Heijde\u00a0D, Ritchlin\u00a0CT et\u00a0al (2017) Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1. Ann Rheum Dis 76:79\u201387","journal-title":"Ann Rheum Dis"},{"key":"1864_CR12","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/rheumatology\/kev296","volume":"55","author":"R Queiro","year":"2016","unstructured":"Queiro\u00a0R, Morante\u00a0I, Cabezas\u00a0I et\u00a0al (2016) HLA-B27 and psoriatic disease: a\u00a0modern view of an old relationship. Rheumatology (Oxford) 55:221\u2013229","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 2","key":"1864_CR13","doi-asserted-by":"publisher","first-page":"ii37","DOI":"10.1136\/ard.2004.030775","volume":"64","author":"P Rahman","year":"2005","unstructured":"Rahman\u00a0P, Elder\u00a0JT (2005) Genetic epidemiology of psoriasis and psoriatic arthritis. Ann Rheum Dis 64(Suppl 2):ii37\u2013ii39 (discussion ii40\u201331)","journal-title":"Ann Rheum Dis"},{"key":"1864_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41590-025-02351-z","volume":"27","author":"MG Raimondo","year":"2026","unstructured":"Raimondo\u00a0MG, Mohammadian\u00a0H, Angeli\u00a0MR et\u00a0al (2026) Skin-derived myeloid precursors and joint-resident fibroblasts spread psoriatic disease from skin to joints. Nat Immunol 27:35\u201347","journal-title":"Nat Immunol"},{"key":"1864_CR15","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1056\/NEJMra1505557","volume":"376","author":"CT Ritchlin","year":"2017","unstructured":"Ritchlin\u00a0CT, Colbert\u00a0RA, Gladman\u00a0DD (2017) Psoriatic Arthritis. N Engl J Med 376:957\u2013970","journal-title":"N Engl J Med"},{"key":"1864_CR16","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nrrheum.2016.102","volume":"12","author":"PC Robinson","year":"2016","unstructured":"Robinson\u00a0PC, Choi\u00a0HK, Do\u00a0R et\u00a0al (2016) Insight into rheumatological cause and effect through the use of Mendelian randomization. Nat Rev Rheumatol 12:486\u2013496","journal-title":"Nat Rev Rheumatol"},{"key":"1864_CR17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/BOR.0000000000001079","volume":"37","author":"VR Rodriguez","year":"2025","unstructured":"Rodriguez\u00a0VR, Essex\u00a0M, Poddubnyy\u00a0D (2025) The gut microbiota in spondyloarthritis: an update. Curr Opin Rheumatol 37:199\u2013206","journal-title":"Curr Opin Rheumatol"},{"key":"1864_CR18","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41584-019-0175-0","volume":"15","author":"JU Scher","year":"2019","unstructured":"Scher\u00a0JU, Ogdie\u00a0A, Merola\u00a0JF et\u00a0al (2019) Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition. Nat Rev Rheumatol 15:153\u2013166","journal-title":"Nat Rev Rheumatol"},{"key":"1864_CR19","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41584-022-00776-6","volume":"18","author":"G Schett","year":"2022","unstructured":"Schett\u00a0G, Rahman\u00a0P, Ritchlin\u00a0C et\u00a0al (2022) Psoriatic arthritis from a mechanistic perspective. Nat Rev Rheumatol 18:311\u2013325","journal-title":"Nat Rev Rheumatol"},{"key":"1864_CR20","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nm.2817","volume":"18","author":"JP Sherlock","year":"2012","unstructured":"Sherlock\u00a0JP, Joyce-Shaikh\u00a0B, Turner\u00a0SP et\u00a0al (2012) IL-23 induces spondyloarthropathy by acting on ROR-\u03b3t+ CD3+CD4-CD8- entheseal resident T cells. Nat Med 18:1069\u20131076","journal-title":"Nat Med"},{"key":"1864_CR21","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1136\/annrheumdis-2022-222415","volume":"81","author":"D Simon","year":"2022","unstructured":"Simon\u00a0D, Fagni\u00a0F, Schett\u00a0G (2022) Sequential interleukin-17\/interleukin-23 inhibition in treatment-refractory psoriatic arthritis. Ann Rheum Dis 81:1334\u20131336","journal-title":"Ann Rheum Dis"},{"key":"1864_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12881-017-0447-y","volume":"18","author":"S Uebe","year":"2017","unstructured":"Uebe\u00a0S, Ehrlicher\u00a0M, Ekici\u00a0AB et\u00a0al (2017) Genome-wide association and targeted analysis of copy number variants with psoriatic arthritis in German patients. BMC Med Genet 18:92","journal-title":"BMC Med Genet"},{"key":"1864_CR23","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1016\/S0140-6736(18)30830-4","volume":"391","author":"DJ Veale","year":"2018","unstructured":"Veale\u00a0DJ, Fearon\u00a0U (2018) The pathogenesis of psoriatic arthritis. Lancet 391:2273\u20132284","journal-title":"Lancet"},{"key":"1864_CR24","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/cei.13020","volume":"190","author":"C Vitulano","year":"2017","unstructured":"Vitulano\u00a0C, Tedeschi\u00a0V, Paladini\u00a0F et\u00a0al (2017) The interplay between HLA-B27 and ERAP1\/ERAP2 aminopeptidases: from anti-viral protection to spondyloarthritis. Clin Exp Immunol 190:281\u2013290","journal-title":"Clin Exp Immunol"},{"key":"1864_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.clim.2016.07.019","volume":"172","author":"R Winchester","year":"2016","unstructured":"Winchester\u00a0R, Giles\u00a0J, Jadon\u00a0D et\u00a0al (2016) Implications of the diversity of class I HLA associations in psoriatic arthritis. Clin Immunol 172:29\u201333","journal-title":"Clin Immunol"},{"key":"1864_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2019-001067","volume":"5","author":"A Zabotti","year":"2019","unstructured":"Zabotti\u00a0A, Mcgonagle\u00a0DG, Giovannini\u00a0I et\u00a0al (2019) Transition phase towards psoriatic arthritis: clinical and ultrasonographic characterisation of psoriatic arthralgia. RMD Open 5:e001067","journal-title":"RMD Open"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-026-01864-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-026-01864-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-026-01864-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:57:55Z","timestamp":1790359075000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-026-01864-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":26,"alternative-id":["1864"],"URL":"https:\/\/doi.org\/10.1007\/s00393-026-01864-8","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"assertion":[{"value":"11 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.\u00a0K\u00f6hm, A.\u00a0K\u00f6nig, I.\u00a0Rzehak, N.\u00a0Ninosu, M.\u00a0Figat und F.\u00a0Behrens geben an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","label":"Interessenkonflikt","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}}]}}